Our data suggest that TWIST1 RNA interference provides additional benefits of nerve regeneration and functional recovery to enhance the efficacy of topical application of ADSCs for peripheral nerve injury treatment, improving their neurotrophic properties and concurrently maintaining them in a neuroinduced state while preserving their stem properties. The gene discussed is TWIST1; the disease is peripheral nerve injury.